The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Ipsen Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
57 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BYLVAY odevixibat 200 microgram capsule bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BYLVAY odevixibat 1200 microgram capsule bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BYLVAY odevixibat 600 microgram capsule bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BYLVAY odevixibat 400 microgram capsule bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for IQIRVO elafibranor 80 mg film-coated tablets bottle.
-
Prescription medicine registrationActive ingredients: odevixibat, odevixibat sesquihydrate.
-
-
Nov-2024Prescription medicine evaluationActive ingredient: cabozantinib (S)-malate.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RELFYDESS relabotulinumtoxinA 100 units/mL solution for injection vial.
-
Australian Public Assessment Report (AusPAR)Sohonos (palovarotene) was approved to treat heterotopic ossification in individuals with fibrodysplasia ossificans progressiva.